Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area ...Middle East

OSAKA, Japan and MONTREAL , Dec. 5, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that it has entered into a drug discovery collaboration agreement with Congruence Therapeutics (Headquarters: Montreal, Quebec,...

Hence then, the article about ono enters into drug discovery collaboration agreement with congruence therapeutics to generate novel small molecule correctors in the oncology area was published today ( Friday 06/12/2024 - 03:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area )

Also on site :

• Pentagon wants killer AI without safeguards – Reuters
• Costco’s $25 Glassware Set Is Giving Anthropologie Vibes for Less
• '90s Grunge Rock Band's Hits Revived in Special Tribute Performance